Syphilis in children: congenital and acquired

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Background:

• Syphilis remains a significant global health concern, impacting millions of adults and pregnancies annually.
• Despite declining rates in the US, limited screening and treatment programs in developing countries perpetuate its worldwide prevalence.
• Treponema pallidum, the causative agent, has a small genome, but in vitro cultivation remains challenging, hindering research and vaccine development.

Purpose of the Study:

• To summarize the current global status of syphilis, including its epidemiology, diagnosis, and treatment.
• To highlight the challenges in controlling syphilis, particularly in resource-limited settings.
• To emphasize the need for international collaboration in syphilis prevention and eradication efforts.

Main Methods:

• Review of existing literature on syphilis epidemiology, diagnosis, and treatment.
• Analysis of global health data pertaining to syphilis prevalence and impact on pregnancies.
• Discussion of diagnostic methods, including serologic testing for antibodies.
• Evaluation of current treatment protocols, with penicillin as the primary choice.

Main Results:

• Syphilis continues to affect over 12 million adults and half a million pregnancies globally each year.
• Prenatal screening and treatment are inadequate in many developing nations.
• Serologic testing is the primary diagnostic tool, and penicillin remains the preferred treatment.
• No viable vaccine candidates are currently available.

Conclusions:

• Syphilis is a preventable and potentially eradicable disease.
• Sustained international cooperation and funding for screening and treatment programs are essential for global syphilis control.
• Addressing disparities in healthcare access is crucial for reducing the burden of syphilis worldwide.